MacroGenics to Participate in Upcoming Investor Conferences
March 08 2019 - 5:30PM
MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage
biopharmaceutical company focused on discovering and developing
innovative monoclonal antibody-based therapeutics for the treatment
of cancer, today announced that the Company's management will
participate in the following investor conferences in March:
- Cowen 39th Annual Health Care Conference. MacroGenics will
participate in one-on-one meetings and provide a corporate overview
at the Boston Marriott Copley Place in Boston on March 12, 2019, at
10:00 a.m. ET.
- Oppenheimer 29th Annual Healthcare Conference.
MacroGenics will participate in one-on-one meetings at the Westin
New York Grand Central on March 20, 2019.
A webcast of the presentation at Cowen may be accessed under
"Events & Presentations" in the Investor Relations section of
MacroGenics' website at http://ir.macrogenics.com/events.cfm. The
Company will maintain an archived replay of this webcast on its
website for 30 days after the conference.
About MacroGenics, Inc.
MacroGenics is a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal
antibody-based therapeutics for the treatment of cancer. The
Company generates its pipeline of product candidates primarily from
its proprietary suite of next-generation antibody-based technology
platforms, which have applicability across broad therapeutic
domains. For more information, please see the Company's website at
www.macrogenics.com. MacroGenics and the MacroGenics logo are
trademarks or registered trademarks of MacroGenics, Inc.
Contacts:
Jim Karrels, Senior Vice President, CFO
MacroGenics, Inc.
1-301-251-5172, info@macrogenics.com
Karen Sharma, Senior Vice President
MacDougall Biomedical Communications
1-781-235-3060, ksharma@macbiocom.com
MacroGenics (NASDAQ:MGNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
MacroGenics (NASDAQ:MGNX)
Historical Stock Chart
From Apr 2023 to Apr 2024